EMEA-002684-PIP02-21 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Haematology-Hemostaseology
PIP number: P/0150/2022
Route(s) of administration: Oral use
Pharmaceutical form(s):
Age-appropriate oral solid dosage form
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-002684-PIP01-19-M01 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Haematology-Hemostaseology
PIP number: P/0030/2022
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Age-appropriate oral solid dosage form
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Ferriprox
deferiprone
beta-Thalassemia
Iron Overload
Date of authorisation:
Revision: 32
Last updated:
MedicineHumanAuthorised
Pyrukynd
mitapivat
Genetic Diseases, Inborn
Anemia, Hemolytic
Date of authorisation:
Last updated:
MedicineHumanAuthorised